home All News open_in_new Full Article

Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting

Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting  GlobeNewswire


today 19 h. ago attach_file Politics



ID: 367385788
Add Watch Country

arrow_drop_down